Stryker CEO Kevin Lobo to Step Down, Spencer Stiles Takes Helm in 2027
Event summary
- Kevin Lobo transitions to Executive Chair of the Board on January 1, 2027, after 14 years as CEO.
- Spencer Stiles, current President and COO, appointed as new CEO effective the same date.
- Lobo tripled Stryker’s annual net sales from $8.7 billion in 2012 to $26 billion in 2026.
- Stiles has led key acquisitions, including Wright Medical, and held leadership roles across Stryker’s business segments.
The big picture
Stryker’s leadership transition comes at a time when the medical technology sector is under pressure to innovate and consolidate. Lobo’s tenure was marked by significant M&A activity, positioning Stryker as a diversified leader in orthopaedics, neurotechnology, and MedSurg. The shift to Stiles, who has deep operational experience, suggests a focus on sustaining growth through strategic execution and potential further acquisitions.
What we're watching
- Leadership Continuity
- How Spencer Stiles will maintain Stryker’s growth momentum amid a leadership transition.
- M&A Strategy
- Whether Stiles will continue Lobo’s aggressive acquisition strategy to drive further expansion.
- Operational Execution
- The pace at which Stiles can integrate his leadership style across Stryker’s diverse business segments.